Oc.02.3 a real life comparison of the effectiveness of adalimumab versus golimumab in moderate-to-severe ulcerative colitis. a multicentre experience from a regional network for inflammatory bowel disease

http://www.dldjournalonline.com/article/S1590-8658(18)30275-5/fulltext?rss=yes

Source: Digestive and Liver Disease - March 15, 2018 Category: Gastroenterology Authors: S. Renna, F. Mocciaro, M. Ventimiglia, R. Orlando, F.S. Macaluso, M. Cappello, W. Fries, M. Mendolaro, A.C. Privitera, C. Ferracane, V. Pisana, A. Magnano, D. Pluchino, G. Inserra, G. Scarpulla, S. Garufi, A. Carroccio, S. Siringo, M. Billeci, R. Dimitri, Tags: Oral Communications Source Type: research